These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 35625986)

  • 1. Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells.
    Machida K; Tahara SM
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35625986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV and tumor-initiating stem-like cells.
    Machida K
    Front Physiol; 2022; 13():903302. PubMed ID: 36187761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy.
    Nakagawa C; Kadlera Nagaraj M; Hernandez JC; Uthay Kumar DB; Shukla V; Machida R; Schüttrumpf J; Sher L; Farci P; Mishra L; Tahara SM; Ou JJ; Machida K
    Front Immunol; 2023; 14():1204907. PubMed ID: 37744383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotency Transcription Factors and Metabolic Reprogramming of Mitochondria in Tumor-Initiating Stem-like Cells.
    Machida K
    Antioxid Redox Signal; 2018 Apr; 28(11):1080-1089. PubMed ID: 29256636
    [No Abstract]   [Full Text] [Related]  

  • 5. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus.
    Machida K
    Drug Deliv Transl Res; 2013 Apr; 3(2):152-64. PubMed ID: 25787983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
    Machida K
    Hepatol Int; 2017 Mar; 11(2):143-147. PubMed ID: 27990610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells.
    Chen CL; Hernandez JC; Uthaya Kumar DB; Machida T; Tahara SM; El-Khoueiry A; Li M; Punj V; Swaminathan SK; Kirtane A; Chen Y; Panyam J; Machida K
    Adv Sci (Weinh); 2023 May; 10(14):e2206812. PubMed ID: 36949364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells.
    Robinson M; Gilbert SF; Waters JA; Lujano-Olazaba O; Lara J; Alexander LJ; Green SE; Burkeen GA; Patrus O; Sarwar Z; Holmberg R; Wang C; House CD
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
    Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
    Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
    Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
    Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of Oct4 in tumor-initiating cells.
    Wang YJ; Herlyn M
    Am J Physiol Cell Physiol; 2015 Dec; 309(11):C709-18. PubMed ID: 26447206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
    J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol.
    Machida K
    Chem Biol Interact; 2020 May; 323():109055. PubMed ID: 32171851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ovarian cancer stem cells or tumor-initiating cells.
    Kwon MJ; Shin YK
    Int J Mol Sci; 2013 Mar; 14(4):6624-48. PubMed ID: 23528891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
    Zhang Y; Guan DX; Shi J; Gao H; Li JJ; Zhao JS; Qiu L; Liu J; Li N; Guo WX; Xue J; Zhou FG; Wu MC; Wang HY; Xie D; Cheng SQ
    J Hepatol; 2013 Dec; 59(6):1255-63. PubMed ID: 23867314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.
    Siddique HR; Feldman DE; Chen CL; Punj V; Tokumitsu H; Machida K
    Hepatology; 2015 Nov; 62(5):1466-79. PubMed ID: 26174965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL11 promotes self-renewal and tumorigenicity of α2δ1
    Zhang Y; Zhao W; Li S; Lv M; Yang X; Li M; Zhang Z
    Cancer Lett; 2019 May; 449():163-171. PubMed ID: 30771435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.